A major new study from Finland has found that adolescents referred for gender identity treatment continue to experience significantly elevated mental health challenges over time, adding to a growing body of research and clinical concern about current approaches to treating gender dysphoria in minors.
The study, published in Acta Paediatrica, analyzed national registry data spanning 1996 to 2019 and tracked approximately 2,100 young people referred to specialized gender identity services. Researchers found that nearly half—about 46%—had already received psychiatric care before referral, rising to nearly 62% within two years afterward.
Compared to their peers, adolescents in the study showed markedly higher levels of psychiatric need both before and after referral. After adjusting for prior treatment, girls were about three times more likely to require additional psychiatric care, while boys were about five times more likely.
The findings reinforce concerns raised in earlier reporting by Christian Daily International on international reviews and medical debates surrounding youth gender treatment, including the landmark Cass Review in the United Kingdom.
That review, commissioned by the National Health Service, concluded that the evidence base supporting medical interventions such as puberty blockers and cross-sex hormones for minors remains limited and uncertain. It also raised concerns about clinical pathways that move too quickly toward medicalization without sufficiently addressing underlying psychological factors.
The Finnish study similarly found that adolescents referred for gender identity services had “significantly higher psychiatric morbidity” prior to treatment—suggesting that gender-related distress often coexists with other mental health conditions. Researchers emphasized the need for thorough psychological assessment and ongoing mental health care, noting that “psychiatric needs must be adequately met.”
Christian Daily International previously reported that pediatricians and medical experts in several countries have warned against what they describe as a “rushed” approach to medical transition for minors. Some clinicians have called for stricter safeguards or a pause on certain interventions, particularly irreversible procedures, citing concerns about long-term outcomes and the quality of supporting evidence.
The Finnish data provides rare long-term insight due to the country’s comprehensive national health system, which allows researchers to track outcomes over decades. It found that psychiatric care needs increased during follow-up even among those who underwent medical interventions, with rates rising sharply in both male-to-female and female-to-male treatment groups.
These findings align with broader international discussions about the natural course of gender dysphoria in youth. Some longitudinal studies have suggested that a significant proportion of children experiencing gender-related distress do not continue to identify as transgender into adulthood, particularly when symptoms emerge before adolescence.
At the same time, recent developments in the United Kingdom—including a closely watched clinical trial involving puberty blockers—have drawn criticism from both evangelical groups and some LGBT advocates who highlighted the long-term harm of medical interventions.
While the Finnish researchers did not advocate for specific policy changes, their study adds weight to calls for a more cautious and holistic approach. By highlighting persistent mental health challenges and the complexity of underlying conditions, the findings contribute to a growing reassessment of the assumption that so-called “gender-affirming care” leads to improved psychological outcomes.
